National Health Investors (NHI) EBITDA (2009 - 2019)

National Health Investors' EBITDA history runs 11 years deep, the most recent figure standing at $42.8 million for Q3 2019.

• Quarterly EBITDA rose 4.33% year-over-year to $42.8 million in Q3 2019, while the trailing twelve-month figure through Sep 2019 was $159.4 million (up 1.15% YoY) and the FY2019 annual result came in at $1.7 billion, up 276.3% from the prior year.
• EBITDA was $42.8 million for Q3 2019 at National Health Investors, up from $40.0 million in the prior quarter.
• Across five years, EBITDA topped out at $46.4 million in Q4 2016 and bottomed at $18.6 million in Q2 2016.
• A 5-year average of $37.8 million and a median of $39.2 million in 2018 frame the typical range for EBITDA.
• Annual changes were most pronounced in 2016 — EBITDA plunged 54.63% — and 2017, when it soared 106.13%.
• National Health Investors' EBITDA stood at $42.1 million in 2015, then advanced by 10.22% to $46.4 million in 2016, then fell by 14.64% to $39.6 million in 2017, then climbed by 3.52% to $41.0 million in 2018, then advanced by 4.33% to $42.8 million in 2019.
• Business Quant data shows NHI's EBITDA at $42.8 million in Q3 2019, $40.0 million in Q2 2019, and $35.7 million in Q1 2019.